Bioloxía de membranas e mecanismos de transducción de sinais en farmacoloxía aplicada.
BioFarma
University Hospitals Bristol NHS Foundation Trust
Brístol, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von University Hospitals Bristol NHS Foundation Trust (1)
2014
-
Gefitinib for oesophageal cancer progressing after chemotherapy (COG): A phase 3, multicentre, double-blind, placebo-controlled randomised trial
The Lancet Oncology, Vol. 15, Núm. 8, pp. 894-904